A potent cancer treatment once threatened the survival of an ancient forest species
In short: Paclitaxel is a cornerstone of modern chemotherapy, yet its discovery nearly triggered an ecological crisis. Initially harvested from the bark of the Pacific yew, the drug’s massive demand required killing thousands of trees. Today, innovative semisynthetic methods and plant cell fermentation have replaced this destructive reliance on wild forests.
Discovered in 1962 through a National Cancer Institute screening program, paclitaxel was isolated from the Pacific yew tree by Monroe Wall and Mansukh Wani in 1971. The compound functions as a taxane, a class of drugs that stabilizes microtubules within cells. By preventing these structures from disassembling, paclitaxel halts mitosis, forcing cancer cells to undergo apoptosis or enter a dormant state. This mechanism proved effective against various malignancies, including ovarian, breast, and lung cancers.
The path to clinical use was fraught with supply challenges. By the late 1980s, researchers estimated that treating all American ovarian and melanoma patients would necessitate the destruction of 360,000 trees annually. This ecological threat prompted a search for sustainable alternatives. While total chemical synthesis was achieved in 1994 by the research groups of Robert Holton and K.C. Nicolaou, these complex processes were never commercially viable. Instead, industry turned to semisynthesis, utilizing 10-deacetylbaccatin extracted from the needles of the European yew, a process pioneered by Pierre Potier and later refined by Holton.
Modern production has evolved further through plant cell fermentation. By cultivating specific Taxus cell lines in large tanks, manufacturers like Phyton Biotech can now produce the drug without harvesting trees. This shift not only preserves biodiversity but also reduces the energy and hazardous chemicals required for production. Despite its success, paclitaxel remains a complex medication; patients often receive dexamethasone beforehand to mitigate side effects like allergic reactions, which are frequently linked to the solvent Cremophor EL used in traditional formulations.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Summary by Intellect · source: Paclitaxel
- Also: Paclitaxel
To cite this card, link to https://intellectplus.co.uk/app/health-paclitaxel.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?
Related
More in Health, medicine and disease · More in Health · Latest · A–Z · All topics